159892-20-3Relevant academic research and scientific papers
PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS
-
Paragraph 523-525, (2021/10/11)
The subject matter described herein is directed to pyruvate kinase activating compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for the treatment of diseases associated with PKR and/or PKM2, such as pyruvate kinase deficiency, sickle cell disease, and beta-thalassemia.
